Sergio A. Munoz
Bellaterra, CT 08193, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
AAV-mediated FGF21 gene therapy promotes health span extension by whole-body tissue-specific adaptations.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 11, 2025
Rat models of musculoskeletal lysosomal storage disorders and their role in pre-clinical evaluation of gene therapy approaches.
Journal: Mammalian genome : official journal of the International Mammalian Genome Society
Published: December 23, 2024
Reversion of metabolic dysfunction-associated steatohepatitis by skeletal muscle-directed FGF21 gene therapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 01, 2024
Treatment of infantile-onset Pompe disease in a rat model with muscle-directed AAV gene therapy.
Journal: Molecular metabolism
Published: July 31, 2023
An ensemble of parameters from a robust Markov-based model reproduces L-type calcium currents from different human cardiac myocytes.
Journal: PloS one
Published: August 13, 2021
AAV-mediated BMP7 gene therapy counteracts insulin resistance and obesity.
Journal: Molecular therapy. Methods & clinical development
Published: July 07, 2021
BMP7 overexpression in adipose tissue induces white adipogenesis and improves insulin sensitivity in ob/ob mice.
Journal: International journal of obesity (2005)
Published: March 10, 2020
FGF21 gene therapy as treatment for obesity and insulin resistance.
Journal: EMBO molecular medicine
Published: July 11, 2018
Long-Term Efficacy and Safety of Insulin and Glucokinase Gene Therapy for Diabetes: 8-Year Follow-Up in Dogs.
Journal: Molecular therapy. Methods & clinical development
Published: March 22, 2017
Last Updated: 09/26/2026